SI-BONE Releases Data on 5,319 Patients Treated With iFuse Implant System

San Juan, Calif.-based SI-BONE released the safety data for the first 5,319 patients treated with the company’s iFuse Implant System for degenerative sacroiliitis and sacroiliac joint disruption.

Advertisement

The study, published in Medical Devices: Evidence and Research, studied procedures in the United Kingdom and Canada from April 2009 to January 2013. The overall post-market complaint rate was 3.8 percent, with a total revision rate of 1.8 percent and a late postoperative revision rate of 0.6 percent.

More Articles on Devices:
TranS1 Completes Acquisition of Baxano Spine Device Manufacturer
RTI Biologics Donates 35 Bone Allograft Implants to Kenyan Children’s Hospital
14 News Updates for Spine & Orthopedic Device Companies

Advertisement

Next Up in Spinal Tech

  • Zavation Medical has acquired ChoiceSpine, and Derek Kuyper will be CEO of the combined company, according to a Feb. 26…

  • Carlsmed saw significant gains in fourth-quarter and 2025 revenue, according to financial results posted Feb. 25. Five things to know:…

Advertisement

Comments are closed.